Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 06, 2025

Get In Touch

Brain-Computer Interface Technology Empowers Fully Paralyzed Patient To Communicate Neurology

Brain-Computer Interface Technology Empowers Fully Paralyzed Patient To Communicate

  • 21 July 2025
  • 3 months ago

Aceneuramic Acid First Approved Drug For GNE Myopathy Treatment, Report Researchers Psychiatry

Aceneuramic Acid First Approved Drug For GNE Myopathy Treatment, Report Researchers

  • 21 July 2025
  • 3 months ago

Routine Cirrhosis Screening In Dementia Patients May Rule Out Hepatic Encephalopathy: JAMA Gastroenterology

Routine Cirrhosis Screening In Dementia Patients May Rule Out Hepatic Encephalopathy: JAMA

  • 21 July 2025
  • 3 months ago

Coffee Consumption Tied To Lower Risk Of Developing Parkinson'S Disease: Study Neurology

Coffee Consumption Tied To Lower Risk Of Developing Parkinson'S Disease: Study

  • 21 July 2025
  • 3 months ago

CAMH Develops Potential New Drug Treatment For Multiple Sclerosis Neurology

CAMH Develops Potential New Drug Treatment For Multiple Sclerosis

  • 21 July 2025
  • 3 months ago

Interstitial Photodynamic Therapy For Newly Diagnosed Glioblastoma Neurology

Interstitial Photodynamic Therapy For Newly Diagnosed Glioblastoma

  • 21 July 2025
  • 3 months ago

Common Antidepressants SSRI And SNRI Found Safe For Most Stroke Survivors Cardiology and CTVS

Common Antidepressants SSRI And SNRI Found Safe For Most Stroke Survivors

  • 21 July 2025
  • 3 months ago

FDA Approves Novel Rehabilitation System For Stroke Victims Physiotherapy

FDA Approves Novel Rehabilitation System For Stroke Victims

  • 21 July 2025
  • 3 months ago

Cinpanemab Fails To Slow Disease Progression In Patients With Early Parkinson'S Disease: NEJM Neurology

Cinpanemab Fails To Slow Disease Progression In Patients With Early Parkinson'S Disease: NEJM

  • 21 July 2025
  • 3 months ago

Erythropoietin Treatment Does Not Provide Neuroprotection To Preterm Infants: NEJM Pediatrics and Neonatology

Erythropoietin Treatment Does Not Provide Neuroprotection To Preterm Infants: NEJM

  • 21 July 2025
  • 3 months ago

Recent News

MBBS, BDS 2025: DME Chhattisgarh issues mop up rou...

  • 06 November, 2025

Only 31 percent families of doctors who died battl...

  • 06 November, 2025

NEET 2025: MP DME releases mop up round allotment...

  • 06 November, 2025

PG Medical Admissions 2025: CEE Kerala publishes f...

  • 06 November, 2025

Venus Remedies expands presence in Vietnam with ma...

  • 06 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.